Development of a matrix to evaluate the threat of biological agents used for bioterrorism

Cellular and Molecular Life Sciences

Volumn 63, Issue 19-20, 2006, Pages 2223-2228

  Tegnell, A ^a   Van Loock, F ^a   Baka, A ^a   Wallyn, S ^a   Hendriks, J ^a   Werner, A ^a   Gouvras, G ^a  

^a European Commission   (Luxembourg)

Author keywords

Bioterrorism; Disaster planning; Europe; Needs assessment; Public health

Indexed keywords

CHEMICAL AGENT;

ANTHRAX; ARENAVIRUS; ARTICLE; BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; BOTULISM; BRUCELLA; BRUCELLOSIS; BURKHOLDERIA MALLEI; CLOSTRIDIUM BOTULINUM; COXIELLA BURNETII; EUROPE; FILOVIRUS; FRANCISELLA TULARENSIS; HEALTH CARE; HEALTH PROGRAM; HEMORRHAGIC FEVER; HORSE DISEASE; HUMAN; INTELLIGENCE; ONLINE ANALYSIS; PATHOGENESIS; PHYTOTOXICITY; PLAGUE; PUBLIC HEALTH; Q FEVER; RICINUS COMMUNIS; SMALLPOX; THREAT; TULAREMIA; UNITED STATES; VIRUS ENCEPHALITIS; YERSINIA PESTIS;

BIOTERRORISM; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; DISASTER PLANNING; HUMANS; NEEDS ASSESSMENT; RISK ASSESSMENT;

EID: 33750473418     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-006-6310-5     Document Type: Article

References (10)

1. Centers for Disease Control and Prevention (2000) Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. MMWR 49 (RR-4): 1-14.
2. Franz, D. R. and Zajtchuk, R. (2000) Biological terrorism: understanding the threat, preparation, and medical response. Dis. Mon. 46, 125-190.
3. Flowers, L. K., Mothershead, J. L. and Blackwell, T. H. (2002) Bioterrorism preparedness. II: The community and emergency medical services systems. Emerg. Med. Clin. North Am. 20, 457-476.
4. Cieslak, T. J. and Eitzen, E. M. Jr (2000) Bioterrorism: agents of concern. J. Public Health Manag. Pract. 6, 19-29.
5. Giovachino, M. and Carey, N. (2001) Modeling the consequences of bioterrorism response. Mil. Med. 166, 925-930.
6. Koplan, J. (2001) CDC's strategic plan for bioterrorism preparedness and response. Public Health Rep. 116 Suppl. 2, 9-16.
7. Christopher, G. W., Cieslak, T. J., Pavlin, J. A. and Eitzen, E. M. Jr (1997) Biological warfare. A historical perspective [see comments]. JAMA 278, 412-417.
8. Franz, D. R., Jahrling, P. B., Friedlander, A. M., McClain, D. J., Hoover, D. L., Bryne, W. R., Pavlin, J. A., Christopher, G. W. and Eitzen, E. M. Jr (1997) Clinical recognition and management of patients exposed to biological warfare agents. JAMA 278, 399-411.
9. Coignard, B. (2001) Bioterrorism preparedness and response in European public health institutes. Euro Surveill. 6, 159-166.
10. Tegnell, A., Bossi P., Baka A., Van Loock, F., Hendriks, J., Wallyn, S. and Gouvras, G. (2003) The European Commission's task force on bioterrorism. Emerg. Infect. Dis. [serial online] 9, 1330-1333. Available from: http://www.cdc.gov/ncidod/EID/vol9no10/03-03-0368.htm